US Patent 7598227 Modulation of apolipoprotein C-III expression
Patent 7598227 was granted and assigned to Ionis Pharmaceuticals on October, 2009 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 7598227 Modulation of apolipoprotein C-III expression
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
